Abstract
Background The surge of 2019 novel coronavirus disease (COVID-19) outbreak was turned to a pandemic with hundreds and thousands of cases reported globally. The number of cases dramatically increased from early March 2020.
Aim We assessed the cumulative change in the incidence and case-fatality rate of COVID-19 at global, regional, and national levels from January – March 16, 2020, across 154 affected countries and territories globally.
Methods We collected data of COVID-19 cases using the GitHub repository, that provided support to real-time surveillance information developed by the Center for Systems Science and Engineering (CSSE), Johns Hopkins University, USA. Information such as confirmed COVID-19 cases, deaths, and recoveries reported across all affected countries was collected from January 22 to March 16, 2020. We estimated the change in the incidence, case-fatality rate, and recovery rate from January 22 to February 29 and March 1 to March 16, 2020.
Results From January 22 to March 16, 2020, globally, COVID-19 incident cases increased by 276.2%, and Europe recorded 65,281 new cases from March 1 to 16, 2020. Overall, the case-fatality rate was 3.92%, and with a high fatality of COVID-19 cases in Italy (7.7%), Iran (5.7%), China (4.2%) and United Kingdom (3.6%). The estimated percentage change in the COVID-19 cases from March 1 to 16, 2020, was highest in Belgium (105.8/100,000 population), followed by Qatar (439/100,000 population) and Portugal (331/100,000 population). However, the overall recovery rate of COVID-19 was found to 43%, China (35.5%) has the highest recovery rate, while the United States of America recorded 0.3%.
Conclusion Overall, all the COVID-19 affected countries showed an upward trend globally, with a little change in the incidence rate of -0.20 from January to Mid-March. The case-fatality rate was found to be 3.92%, and the recovery rate was observed to be less than half (43%) among COVID-19 patients. Italy, Iran, and Spain carried the most substantial new cases of COVID-19 from March 1 to 16, 2020.
Introduction
During early January, a cluster of pneumonia cases of unknown etiology from Wuhan, Hubei Province in China, was identified as novel coronavirus now referred to as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the illness as coronavirus disease (COVID-19) [1]. During January, the COVID-19 spread all over the Wuhan with several cases, and other countries started to report their first cases of the disease. The outbreak of COVID-19 is continued to spread around the world and became a significant public health problem [2]. Subsequently, several hundred and thousands of cases are reported around the world, and on March 11, 2020, the World Health Organization declared COVID-19 a pandemic [3].
As of March 27, 2020, over half a million cases of COVID-19 have been reported across 199 countries, and more than 22,000 deaths had been reported [4]. Currently, the dynamics of COVID-19 put tremendous strain on everyone across countries, citizens, resources, and economies. In the absence of antiviral treatment or vaccine against SARS-CoV-2, preventive measures such as hand hygiene practices, social distancing measures, movement restrictions, self-quarantines, closure of institutions, and other interventions were intensified [5]. As these interventions are gradually implemented, early epidemiological estimates of COVID-19 distribution, cumulative changes in the incidence, and case-fatality rate are crucial for effective interventions. Therefore, we assessed the cumulative change in the incidence and case-fatality rate of COVID-19 at global, regional, and national levels from January 22 – March 16, 2020, across 154 affected countries and territories globally.
Methods
We used the GitHub data repository, a publicly available data of the new confirmed COVID-19 cases on daily series in our analysis [6]. First, we extracted the data of confirmed cases, death, and recovery information reported from January 22 to March 16, 2020. Second, the collected information was filtered and categorized into regions. These data were used to assess the trends of COVID-19 cases, case-fatality rate, and recovery rates at the global, regional, and national levels. Thus, we calculated the relative change in the incident cases and deaths reported from each country and territories, truncated percentage changes in the new cases, and case-fatality rate during January 22 – March 16, 2020 period. We also reported the recovery rate of notified cases in each country.
Statistical analysis
Frequencies and percentages were used to summarize the information. The case fatality rate was defined as = (number of deaths reported/total number of cases) × 100. The estimated percentage change was calculated using the formula: (y2-y1)/y1)*100. Where y1= initial value and y2= end value. All the statistical analysis was conducted using the STATA 16 data analysis and statistical software (StataCorp, LLC, TX, USA).
Results
As of March 16, 2020, the global incident cases of COVID-19 increased to 181,546 cases across 154 countries and territories, with a case-fatality rate of 3.92% and the recovery rate of 43%. The distribution of COVID-19 at the regional and national level are presented in Table 1. For the European and North American countries, the number of new cases showed an upward trend, and Europe reported a high case fatality rate (4.2%) than Asia (3.8%). By the Mid of March, China (n=81033) Italy (n=27980), and Iran (n=14991), Spain (n=9942), South Korea (n=8236) and Germany (n=7272) reported a higher number of COVID-19 cases. However, of these, Italy (7.7%), Iran (5.7%), and China (4.2%) reported a higher mortality rate than global trends (3.9%).
From January to March 16, 2020, the COVID-19 incidence increased in a total of 154 countries (Figure 1A). Within a short period, the COVID-19 cases dramatically increased all over the world except for some sub-Saharan African countries. From March 1 to 16, 2020, more COVID-19 incident cases increased in a total of 152 countries (Figure 1B). The percent change in the incidence cases were less than 1000% in 70 countries including China (102%), while the greatest increase of percentage change was observed in Belgium (1058/100,000 population), Qatar (439/100,000 population), Portugal (33,100%), and Denmark (310.6/100,000 population).
Globally from January to March 16, 2020, the number of new COVID-19 cases worldwide increased by 276.2% from 555 cases to 153,312 [Table 2]. With a decline in the number of new cases in China, a slight change in the incidence of -0.20% noticed during the first half of March 2020. However, the most pronounced increase of new COVID-19 cases was observed in Europe by 66,749%, from “0” cases in January 1467 cases - February, to 65,281 cases until Mid-March, 2020. The countries and territories experienced an increase in the incidence cases, except in China, -0.97%, and cases reported from a Cruise ship (-1.01%). In March, South Korea (0.62%), Singapore (0.38%), and Thailand (1.68%) showed a decrease in the COVID-19 incidence rates compared to the previous period.
A total of 7126 COVID-19 deaths occurred globally until March 16, 2020, with a relative change of 242.2% compared to the deaths that occurred until the end of February 2020 (Figure 2A). From March 1 to 16, the relative increase in the incidence of deaths was observed in Iran (8.53%) and Spain (3.42%) (Figure 2B).
Discussion
Between January 22 and March 16, 2020, a massive incidence of COVID-19 cases rapidly increased across the globe, and thousands of deaths reported in several countries. Our results indicate that the global trends of ongoing COVID-19 pandemic rapidly emerge in all the countries during early March 2020, and the observed trends in the incidence were increased by 276.2%. In particular, an increase in incidence rates and mortality were prominently in most regions worldwide (albeit the majority of cases still occurred in China and Italy). Nevertheless, the incidence of COVID-19 cases varies significantly between countries and regions. The difference between the highest and the lowest incidence was 1088-fold (Belgium: 1058 versus China: 0.97), and the mortality was 26.6 folds (Italy: 7.71 versus Austria: 0.29). It is worth noting that countries such as South Korea, Singapore, and Thailand showed a decreasing trend in the COVID-19 incidence rates in early March 2020.
Our estimates of the case-fatality rate of COVID-19 in Italy and Iran are nearly double that of the global case -fatality rate (3.9%). These findings suggest that the situation in these countries. This suggests that the situation of COVID-19 in these countries are particularly dire and require intensive support to halt the fatalities. Moreover, insufficient healthcare resources in many countries, inadequate screening among travelers, lack of preparedness of healthcare workers, misconceptions among the general public can lead to substantial diagnosis gaps, which may have to cause the disproportionate distribution in incidence and mortality. Our data are following the estimates of the worldwide incidence and mortality from WHO, United States centers for disease control and preventions (CDC), and European center for disease prevention and control (ECDC) [7-9]. Corresponding to the regional variations in the incidence cases of COVID-19 from March 1 to 16, with the highest values in South America and Africa and the lowest in Australia and parts of Asia.
Improvement in early screening, diagnosis, and strictly following the preventive measures may play a key role in halting the global epidemiological transition, including incident cases, death. It might sharp change in the observed in China, Singapore, Hongkong, Taiwan, and South Korea [10-12]. Indeed, the relative mainland in China and neighboring countries experienced a sharp increase in incidence trends in February 2020, as well as in death. The following reasons may contribute to gradual level off in incidence cases: a) responding aggressively by implementing travel restrictions on passengers to prevent transmissions [13], b) early recognition and epidemic preparedness with 124 “action items,” including border control, schools, and work policies [14] and (c) rigorous detection and strict quarantine measure to break long-chain of COVID-19 outbreak [15]. However, further epidemiological analysis addressing the current situation, knowledge gaps in its etiology, comprehensive management of COVID-19 at national and regional levels are warranted.
The study has some unavoidable limitations. Our analysis relies on epidemiologic data reported through March 16, 2020. Therefore, the accuracy of results depends on the quality of the data reported. In terms of quality, the center for systems science and engineering (CSSE) at John Hopkins University, USA obtained confirmed information from respective centers prior to information and is coordinated by a team of experts from John Hopkins University [16]. Most of the information presented in the GitHub repository by CSSE is consistent with the data reported by the WHO [16]. There may be missing information due to limited reporting resources, delay in investigations, reluctant to update the information in some countries. Thus, information bias is inevitable. Due to the limitations of the data, we cannot do further investigation on the clinical, etiological, treatment and risk stratification of the COVID-19 cases.
Conclusion
Overall, all the COVID-19 affected countries showed an upward trend globally, with a little change in the incidence rate of -0.20 from January to Mid-March. The case-fatality rate was found to be 3.92%, and the recovery rate was observed to be less than half (43%) among COVID-19 patients. Italy, Iran, and Spain carried the most substantial new cases of COVID-19 from March 1 to 16, 2020.
Data Availability
Data is readily available upon contacting the corresponding author.
Authors’ contributions
ASB, JR designed the study, developed the study, collected the data, analyzed the data, and prepared the manuscript. WAA, PK and AR designed the study tools, conducted the analysis, and conducted the literature review. ASB, WAA, PK and JR filtered and analyzed the data. All authors read and approved the final manuscript.
Funding
No source of funding
Available data and materials
All data obtained through data respiratory are readily available and can be contacted to corresponding author.
Consent for publication
Not applicable.
Competing interests
The authors declare that they have no competing interests.
Acknowledgment
We thank all the John Hopkins institute, USA for providing the data study participants for their voluntary participation and for providing essential information.